Company Overview
Cerenome, Inc. is a clinical-stage pharmaceutical company. The firm focuses on the development of chemotherapeutics and radio therapeutics for rare cancers that address unmet medical and market needs. Its products include Rhenium NanoLiposome and DocePLUS. The company was founded by Ralph E. Holmes and Christopher J. Calhoun in July 1996 and is headquartered in Houston, TX.
Key Highlights
- Medical - Pharmaceuticals · Healthcare
- Led by Marc H. Hedrick
- 28 employees
- Based in Houston, TX
Price History
Loading…
Data from Twelve Data. Prices may be delayed.
Analyst Coverage
View All Coverage →No analyst coverage available.
Economic Calendar
View more →- Nov 4
ADP Employment Report
8:15 AM ET
- Nov 5
Initial Jobless Claims
8:30 AM ET
- Nov 6
Employment Situation (NFP)
8:30 AM ET
- Nov 6
G.19 - Consumer Credit
3:00 PM ET
Crypto Prices
View more →
Bitcoin (BTC)
77,326 +0.88%
Company Facts
- Sector
- Healthcare
- Industry
- Medical - Pharmaceuticals
- Headquarters
- Houston, TX, US
- Incorporated
- Aug 3, 2026
- Website
- www.plustherapeutics.com
Latest SEC Filings
View All Filings →No SEC filings found.
Investor Presentation
No recent presentation found in SEC filings.
AI Company Summary
Cerenome, Inc. is a clinical-stage pharmaceutical company. The firm focuses on the development of chemotherapeutics and radio therapeutics for rare cancers that address unmet medical and market needs. Its products include Rhenium NanoLiposome and DocePLUS. The company was founded by Ralph E. Holmes and Christopher J. Calhoun in July 1996 and is headquartered in Houston, TX.
